Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 8/2006

01-10-2006 | Original Paper

Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States)

Authors: Patricia Hartge, Unhee Lim, D. Michal Freedman, Joanne S. Colt, James R. Cerhan, Wendy Cozen, Richard K. Severson, Scott Davis

Published in: Cancer Causes & Control | Issue 8/2006

Login to get access

Abstract

Objective

Because of conflicting findings about the relationship between ultraviolet (UV) radiation and the risk of non-Hodgkin lymphoma (NHL), we evaluated the risk of several indicators related to UV, including two not previously studied: dietary vitamin D, and ambient UV levels by residential location.

Methods

As part of a case–control study conducted in four Surveillance, Epidemiology, and End Results (SEER) registries, we collected UV information from a self-administered questionnaire and computer-assisted personal interview with 551 NHL cases and 462 controls. We estimated the relative risk (RR) and 95% confidence intervals (CI) from unconditional logistic regression models.

Results

Eye color, a marker of host susceptibility to UV, showed a decreasing risk gradient for lightest eyes (0.47) compared to darkest. Relative risks were in the range of 0.73–0.78 for participants reporting more hours in the mid-day summer sun. Use of sunlamps or tanning booths was associated with decreased risk (RR = 0.88), as was estimated overall ambient UV (RR = 0.76 per 50 RB-units) overall. Vitamin D intake from diet and supplements was not related to risk. Results were thus consistent for the various indicators, although some estimated risks were not statistically significant. Effects were generally similar for diffuse large B-cell (DLBCL) and follicular lymphomas.

Conclusion

These data suggest a slight protective effect of sunlight against NHL, and they agree with geographic patterns of NHL incidence observed in the US.
Literature
1.
Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J (1992) Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935–1988. Cancer 70:840–849PubMedCrossRef
2.
Cartwright R, McNally R, Staines A (1994) The increasing incidence of non-Hodgkin’s lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 14:387–394PubMed
3.
McMichael AJ, Giles GG (1996) Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin’s lymphoma? Br J Cancer 73:945–950PubMed
4.
Bentham G (1996) Association between incidence of non-Hodgkin’s lymphoma and solar ultraviolet radiation in England and Wales. BMJ 312:1128–1131PubMed
5.
Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF Jr (1996) Non-Hodgkin’s lymphoma and sunlight. J Natl Cancer Inst 88:298–300PubMed
6.
Freedman DM, Zahm SH, Dosemeci M (1997) Residential and occupational exposure to sunlight and mortality from non-Hodgkin’s lymphoma: composite (threefold) case–control study. BMJ 314:1451–1455PubMed
7.
Grant WB (2003) Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 164:371–377PubMed
8.
Hu S, Ma F, Collado-Mesa F, Kirsner RS (2004) Ultraviolet radiation and incidence of non-Hodgkin’s lymphoma among Hispanics in the United States. Cancer Epidemiol Biomarkers Prev 13:59–64PubMedCrossRef
9.
Adami J, Frisch M, Yuen J, Glimelius B, Melbye M (1995) Evidence of an association between non-Hodgkin’s lymphoma and skin cancer. BMJ 310:1491–1495PubMed
10.
Adami J, Gridley G, Nyren O, et al (1999) Sunlight and non-Hodgkin’s lymphoma: a population-based cohort study in Sweden. Int J Cancer 80:641–645PubMedCrossRef
11.
Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N (2001) Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 12:552–557PubMedCrossRef
12.
van Wijngaarden E, Savitz DA (2001) Occupational sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Med 43:548–553PubMed
13.
Hughes AM, Armstrong BK, Vajdic CM, et al (2004) Sun exposure may protect against non-Hodgkin lymphoma: a case–control study. Int J Cancer 112:865–871PubMedCrossRef
14.
Hughes AM, Armstrong BK, Vajdic CM, et al (2004) Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. Int J Cancer 110:429–434PubMedCrossRef
15.
Smedby KE, Hjalgrim H, Melbye M, et al (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97:199–209PubMedCrossRef
16.
Egan KM, Sosman JA, Blot WJ (2005) Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst 97:161–163PubMed
17.
Hartge P, Colt JS, Severson RK, et al (2005) Residential herbicide use and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 14:934–937PubMedCrossRef
18.
Lim U, Schenk M, Kelemen LE, et al (2005) Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin’s lymphoma: NCI-SEER case–control study, 1998–2000. Am J Epidemiol 162:953–964PubMedCrossRef
19.
Chatterjee N, Hartge P, Cerhan JR, et al (2004) Risk of non-Hodgkin’s lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 13:1415–1421PubMed
20.
Scotto J, Cotton G, Urbach F, Berger D, Fears T (1988) Biologically effective ultraviolet radiation: surface measurements in the United States, 1974 to 1985. Science 239:762–764PubMed
21.
Cerhan JR, Bernstein L, Severson RK, et al (2005) Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control 16:1203–1214PubMedCrossRef
22.
Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124:453–469PubMed
23.
Block G, Coyle LM, Hartman AM, Scoppa SM (1994) Revision of dietary analysis software for the Health Habits and History Questionnaire. Am J Epidemiol 139:1190–1196PubMed
24.
Block G, Woods M, Potosky A, Clifford C (1990) Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 43:1327–1335PubMedCrossRef
25.
Subar AF, Thompson FE, Kipnis V, et al (2001) Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America’s Table Study. Am J Epidemiol 154:1089–1099PubMedCrossRef
26.
Willett WC. (1998) Nutritional epidemiology. 2nd ed. Oxford University Press, New York, NY
27.
Hartge P, Devesa SS (1992) Quantification of the impact of known risk factors on time trends in non-Hodgkin’s lymphoma incidence. Cancer Res 52:5566s–5569sPubMed
28.
Franceschi S, Serraino D, Carbone A, Talamini R, Lavecchia C (1989) Dietary factors and non-Hodgkin’s lymphoma: a case–control study in the northeastern part of Italy. Nutr Cancer 12:333–341PubMedCrossRef
29.
Tavani A, Pregnolato A, Negri E, et al (1997) Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27:256–260PubMed
30.
Zheng T, Holford TR, Leaderer B, et al (2004) Diet and nutrient intakes and risk of non-Hodgkin’s lymphoma in Connecticut women. Am J Epidemiol 159:454–466PubMedCrossRef
31.
Purdue MP, Bassani DG, Klar NS, Sloan M, Kreiger N (2004) Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case–control analysis. Cancer Epidemiol Biomarkers Prev 13:1665–1676PubMed
32.
Ursin G, Bjelke E, Heuch I, Vollset SE (1990) Milk consumption and cancer incidence: a Norwegian prospective study. Br J Cancer 61:456–459PubMed
33.
Ward MH, Zahm SH, Weisenburger DD, et al (1994) Dietary factors and non-Hodgkin’s lymphoma in Nebraska (United States). Cancer Causes Control 5:422–432PubMedCrossRef
34.
Zhang S, Hunter DJ, Rosner BA, et al (1999) Dietary fat and protein in relation to risk of non-Hodgkin’s lymphoma among women. J Natl Cancer Inst 91:1751–1758PubMedCrossRef
35.
Chiu B, Cerhan J, Folsom A, Sellers T, Kushi L, Wallace R (1996) Diet, risk of non-Hodgkin’s lymphoma in older women. J Am Med Assn 275:1315–1321CrossRef
36.
Matsuo K, Hamajima N, Hirose K, et al (2001) Alcohol, smoking, and dietary status and susceptibility to malignant lymphoma in Japan: results of a hospital-based case–control study at Aichi Cancer Center. Jpn J Cancer Res 92:1011–1017PubMed
37.
De Stefani E, Fierro L, Barrios E, Ronco A (1998) Tobacco, alcohol, diet and risk of non-Hodgkin’s lymphoma: a case–control study in Uruguay. Leuk Res 22:445–452PubMedCrossRef
38.
Webb AR, Holick MF (1988) The role of sunlight in the cutaneous production of vitamin D3. Annu Rev Nutr 8:375–399PubMedCrossRef
39.
Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80:1678S–1688SPubMed
40.
Vieth R, Cole DE, Hawker GA, Trang HM, Rubin LA (2001) Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 55:1091–1097PubMedCrossRef
41.
Ovesen L, Andersen R, Jakobsen J (2003) Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 62:813–821PubMedCrossRef
42.
Morton LM, Hartge P, Holford TR, et al (2005) Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 14:925–933PubMedCrossRef
43.
Morton LM, Zheng T, Holford TR, et al (2005) Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 6:469–476PubMedCrossRef
Metadata
Title
Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States)
Authors
Patricia Hartge
Unhee Lim
D. Michal Freedman
Joanne S. Colt
James R. Cerhan
Wendy Cozen
Richard K. Severson
Scott Davis
Publication date
01-10-2006
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 8/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0040-8

Other articles of this Issue 8/2006

Cancer Causes & Control 8/2006 Go to the issue

Hypothesis Paper

Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate?

Brief Report

Obesity and the risk of Hodgkin lymphoma (United Kingdom)

Original Paper

Serum transforming growth factor-β1 levels and pancreatic cancer risk: a nested case–control study (Japan)

Review Article

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

Original Paper

Patterns of cancer incidence among US Hispanics/Latinos, 1995–2000

Original Paper

UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits